X4 Pharmaceuticals Details Mavorixafor Phase 3 Push, Cost Cuts and Chronic Neutropenia Market Plan

Executive Chair Adam Craig said the company’s near-term focus is centered on advancing mavorixafor in chronic neutropenia, as ...

OpenClaw founder Steinberger joins OpenAI, open-source bot becomes foundation

Peter Steinberger, the founder of OpenClaw, is joining OpenAI, and the open-source bot is becoming a foundation, OpenAI CEO Sam Altman said on Sunday.